VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TVTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TVTXTravere Therapeutics, Inc.
$58.85$5.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTVTXPrice History

TVTX logoTravere Therapeutics, Inc. (TVTX) Stock Price History

Historical prices from 2012 to 2026

$58.85-0.18  (-0.30%)close Jun 26
Returns
1M
+32.9%
3M
+110.8%
YTD
+48.9%
1Y
+289.0%
3Y
+54.5%
5Y
+30.6%
ATH$60.10Jun 2026-2.1%
ATL$1.50Nov 2012pre-split
Avg Vol (50D)2.1M/ day
52-Week Range$14.36 — $60.10
LowCurrent: $58.85High

Loading 10-year price history...

TVTX Historical Performance

1 YearTotal Return
+278.5%
Price: +289.0%
3 YearsTotal Return
+261.2%
CAGR: +53.4%
Price: +268.5%
5 YearsTotal Return
+274.1%
CAGR: +30.2%
Price: +280.2%
YTD
+48.9%

TVTX Annual Returns

Year-by-year price performance · 2012–2026

Best+123.3%2012
Worst-56.5%2023
Up years11/15
2012+123.3%
2013+118.8%
2014+53.0%
2015+52.2%
2016+0.2%
2017+14.2%
2018+0.7%
2019-37.4%
2020+96.5%
2021+15.0%
2022-31.3%
2023-56.5%
2024+82.2%
2025+101.4%
2026-24.6%
2012 annual price return
+123.3%
2013 annual price return
+118.8%
2014 annual price return
+53.0%
2015 annual price return
+52.2%
2016 annual price return
+0.2%
2017 annual price return
+14.2%
2018 annual price return
+0.7%
2019 annual price return
-37.4%
2020 annual price return
+96.5%
2021 annual price return
+15.0%
2022 annual price return
-31.3%
2023 annual price return
-56.5%
2024 annual price return
+82.2%
2025 annual price return
+101.4%
2026 annual price return
-24.6%
LessMore
Alpha vs S&P 500
1Y+257.7%
3Y+32.0%
5Y+18.8%

Price returns only.

Download Historical Data

3,428 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

TVTX Stock Price Trajectory (2012–2026)

As of June 29, 2026, Travere Therapeutics, Inc. (TVTX) trades at $58.85, representing a +289.0% return over the past year. The stock has delivered a +274.1% total return over five years (+30.6% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $60.10 on June 25, 2026. From this peak, TVTX has corrected -2.1%, currently trading 70% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers RARE (-17.1% 1Y), FOLD (+154.7% 1Y), and ACAD (+14.0% 1Y), TVTX has outperformed the peer group average. Compare TVTX vs RARE →

TVTX Historical Price Data · from 2012

Rows 1–50 of 3,428
Date Open High Low Close Volume Change %
2026-06-2659.3459.8157.6958.850-0.30%
2026-06-2557.8560.1057.2959.032.69M+2.32%
2026-06-2456.5557.8556.0257.692.41M+3.11%
2026-06-2354.5656.0154.1355.951.53M+1.52%
2026-06-2256.3856.8155.0055.111.66M-0.07%
2026-06-1855.0955.9953.7555.154.95M+1.87%
2026-06-1753.7755.1053.0654.141.23M+1.42%
2026-06-1653.8854.3852.7253.381.74M-0.78%
2026-06-1552.4453.8852.0653.802.06M+3.38%
2026-06-1249.1052.7248.9852.042.38M+6.40%
2026-06-1146.5849.5746.5448.912.39M+4.64%
2026-06-1047.5649.6846.7046.741.59M-3.77%
2026-06-0947.8849.2146.7448.572.21M+3.16%
2026-06-0846.6048.2945.9347.081.88M+2.82%
2026-06-0546.2347.7145.3145.792.58M-0.84%
2026-06-0445.4547.5644.6946.181.39M+2.17%
2026-06-0343.3145.5743.0945.201.76M+5.21%
2026-06-0244.0644.7042.3842.962.25M-4.62%
2026-06-0146.6046.8845.0245.041.30M-4.54%
2026-05-2947.7648.5446.5047.181.87M-1.21%
2026-05-2847.6348.5046.9247.761.82M0.00%
2026-05-2744.3348.0244.1647.763.08M+7.83%
2026-05-2644.4345.5343.7044.291.81M-0.32%
2026-05-2244.4044.4644.4044.43803K-0.69%
2026-05-2142.9944.9442.8444.741.32M+2.87%
2026-05-2042.7243.6942.0643.491.54M+2.91%
2026-05-1942.5142.9841.4842.261.23M-1.47%
2026-05-1842.8243.4642.1442.891.67M+0.70%
2026-05-1543.4943.9542.3542.591.59M-3.42%
2026-05-1444.9844.9843.0444.103.01M-1.01%
2026-05-1342.4344.9342.2744.552.47M+3.99%
2026-05-1243.1243.5442.1642.841.74M-1.54%
2026-05-1142.6043.6641.5543.512.27M+2.14%
2026-05-0843.4243.8841.7742.602.25M-0.14%
2026-05-0745.9345.9742.2542.669.89M-4.70%
2026-05-0644.0744.8942.5044.772.38M-0.08%
2026-05-0546.3648.5243.0944.803.00M-0.24%
2026-05-0444.1245.4343.7644.912.37M+1.79%
2026-05-0142.4244.7042.0944.122.10M+4.75%
2026-04-3040.8042.6940.3442.122.49M+5.04%
2026-04-2940.0441.1339.7540.101.30M-1.93%
2026-04-2840.9742.0840.7540.891.17M+0.20%
2026-04-2740.5941.4340.5040.81983K+0.77%
2026-04-2441.3541.3539.9640.501.22M-0.78%
2026-04-2340.1941.6539.7840.821.76M+1.82%
2026-04-2239.0940.1138.3540.092.26M+3.38%
2026-04-2140.4740.4738.4738.781.58M-3.75%
2026-04-2040.7640.8739.3040.291.37M-1.18%
2026-04-1740.2740.8738.6740.771.87M+3.11%
2026-04-1639.7440.0038.1239.543.88M-3.44%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TVTX — Frequently Asked Questions

Quick answers to the most common questions about buying TVTX stock.

How has TVTX stock performed recently?

TVTX returned +289.0% over the past year, beating its 5-year annualized CAGR of +30.6%. The stock trades above its 200-day moving average, confirming the uptrend.

What is TVTX's all-time high price?

Travere Therapeutics, Inc. reached $60.10 on 2026-06-25. The 52-week high is $60.10. Current 1-year return of +289.0% places the stock closer to historical peaks.

Where can I download TVTX historical price data?

This page provides TVTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2012-2026, downloadable in CSV format.

491 data points · sampled from 3,428